Advanced Prosthetic Control Algorithm for Limb Weakness
Trial Summary
What is the purpose of this trial?
The purpose of this study is to improve control of myoelectrically-controlled advanced orthotic devices (an exoskeleton device that use the body's muscle signals to drive movements of a robotic brace) by using advanced predictive decode algorithms, and the use of high count (\> 8) surface electromyographic (sEMG) electrodes.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Advanced Prosthetic Control Algorithm for Limb Weakness?
Research shows that continuous myoelectric control, which is part of the advanced prosthetic control algorithm, allows amputees to adapt their muscle activation to improve prosthetic function, especially with visual feedback. Additionally, pattern recognition myoelectric control, another component, has been found to outperform direct control in terms of efficiency and speed, suggesting its potential effectiveness in prosthetic applications.12345
What makes the Advanced Prosthetic Control Algorithm treatment unique for limb weakness?
The Advanced Prosthetic Control Algorithm is unique because it uses myoelectric signals (electrical signals from muscles) to control prosthetic limbs, allowing for more precise and adaptable movement control compared to traditional mechanical or microprocessor-controlled prostheses. This approach enhances the functionality of prostheses by enabling better control during both weight-bearing and non-weight-bearing activities.36789
Eligibility Criteria
This trial is for individuals who have had their first-ever stroke at least 6 months ago, resulting in paresis or hemiparesis. They must be able to move the arm opposite of the affected side but cannot currently be incarcerated.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants use the orthotic device with different control algorithms for up to 2 hours
Follow-up
Participants are monitored for safety and effectiveness after using the device
Treatment Details
Interventions
- Commercially Available Control Algorithm
- Experimental Control Algorithm
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Utah
Lead Sponsor